Schizophrenia. Epilepsy. Tinnitus. Hundreds of millions of people live with these every day — yet they’ve stayed underfunded and overlooked for years. A new company called Tortugas Neuroscience is trying a different approach. They didn’t start with just an idea. They launched with $231M already raised and real drug candidates already in clinical trials. Instead of spending years guessing what might work, they picked up promising, de-risked treatments and built a team that knows how to actually get them approved and into patients’ hands. It’s a smarter play: less hype, more execution. For a long time, neuroscience has taken a back seat to areas like cancer and immunology. Tortugas is betting that gap is the opportunity — and investors are clearly paying attention. If they get this right, it won’t just be another biotech story. It could mean real progress for conditions people have been waiting far too long to see treated properly. #Neuroscience #Biotech #MentalHealth #Epilepsy #H...